Michael D. Clayman

Insider Reports History

Entity
Individual
Location
C/O Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington, MA
Signature
/s/ Mark S. Levine, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael D. Clayman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 Nov 19, 2021 By the Michael D.Clayman 2006 Revocable Trust
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 Nov 19, 2021 By the Michael D. Clayman Irrevocable Trust
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 Nov 19, 2021 By Versant Development Fund III, LLC
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 Nov 19, 2021 Direct
Flexion Therapeutics Inc President and CEO, Director Performance Restricted Stock Unit Award 0 Nov 19, 2021 Direct
Flexion Therapeutics Inc President and CEO, Director Stock Option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by Michael D. Clayman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FLXN Flexion Therapeutics Inc Nov 19, 2021 13 -$9.54M 4 Nov 19, 2021 President and CEO, Director
FLXN Flexion Therapeutics Inc Jul 19, 2021 1 $0 4 Jul 20, 2021 President and CEO, Director
FLXN Flexion Therapeutics Inc Jun 21, 2021 1 $13.2K 4 Jun 28, 2021 President and CEO, Director